Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For people with schizophrenia:
- People who have been diagnosed with schizophrenia based on a standard set of diagnostic guidelines called DSM-5
- People aged between 18 and 55 years
- People whose condition is currently stable, meaning no hospital stay or change in medication in the past month
- People who have completed at least primary school education
- People who are able to give informed consent to participate in the study
- People who are right-handed (this is required to keep the brainwave recording process consistent across participants)
For healthy volunteers (comparison group):
- People with no history of mental health or neurological conditions
- People whose age and gender are matched to participants in the schizophrenia group
- People who are not currently taking any medication that affects the brain or nervous system
- People who are able to give informed consent to participate in the study
- People who are right-handed
Who may not be able to join:
- People who have had a problem with alcohol or drug use disorder within the past year
- People who have a neurological condition such as epilepsy or a past serious head injury
- People who are currently taking benzodiazepines or other medications known to significantly affect thinking and memory
- People with an intellectual disability, or those who score below 20 on a standard cognitive screening test called the MoCA
- People with significant vision or hearing difficulties that could interfere with completing the study tasks
- People who have taken part in a psychological therapy or intervention program within the past three months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Gökben Hızlı Sayar, Professor, Üsküdar University
Phone: 00905322575880
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from Baseline in P300 Amplitude Measured via EEG at 12 Weeks
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.